decision-making in metastatic her2 breast cancer
Published 3 years ago • 268 plays • Length 5:55Download video MP4
Download video MP3
Similar videos
-
1:12
ctdna in breast cancer: clinical decision making and future perspectives
-
1:12
impact of genomic testing on treatment decision-making in breast cancer
-
3:32
sequencing novel her2-targeted therapies in metastatic breast cancer
-
1:22
impact of ai on patient decision making in breast cancer
-
3:15
brain metastases in her2 breast cancer
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
1:27
impact of genomic tools on decision making in breast cancer
-
4:53
comparing therapy benefit from initially her2 positive or negative metastatic breast cancer patients
-
2:10
treating cns metastases in her2 breast cancer
-
1:25
current state of cdk4/6 inhibitors in metastatic her2-negative breast cancer
-
1:05
the genomic characterization of primary and metastatic her2-low breast cancers
-
2:08
recent progress in managing brain metastasis in breast cancer
-
1:12
trastuzumab deruxtecan in metastatic her2 breast cancer
-
2:14
survival in premenopausal hr /her2- breast cancer with micro-metastasis and 21-gene score
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
0:47
advancing precision medicine: cell-free dna fragment omics in metastatic her2-negative breast cancer
-
1:01
future of breast cancer care: her2 therapies in earlier settings & de-escalation
-
1:30
tucatinib in her2 breast cancer with leptomeningeal metastases
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer